Amplify Weight Loss Drug & Treatment ETF NVO Holdings History
Amplify Weight Loss Drug & Treatment ETF's Novo Nordisk AS Holding Summary
As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 7,831.00 shares of Novo Nordisk AS(NVO), totaling $543,780.00. This investment constitutes 14.42% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 3 purchases of NVO, at an average price of $119.39, for a total of 7,831.00 shares. Based on historical transaction data and NVO's current price of $69.32, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his NVO holdings is $-392,084.97, reflecting a -41.94% gain to date.
Amplify Weight Loss Drug & Treatment ETF NVO ($69.32) Holding Chart
Amplify Weight Loss Drug & Treatment ETF NVO ($69.32) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
